Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis

PURPOSE: This meta-analysis compared the long-term (12 months or 24 months) efficacy and safety of intravitreal aflibercept injection (IAI) for diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR). METHODS: We selected 16 randomized controlled trials (RCTs) performed after 2015...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiao, Lian, Chao, Zhang, Zhiping, Feng, Meng, Wang, Wenqi, Yuan, Xiaomeng, Shi, Yanmei, Liu, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227619/
https://www.ncbi.nlm.nih.gov/pubmed/37260449
http://dx.doi.org/10.3389/fendo.2023.1144422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227619/
https://www.ncbi.nlm.nih.gov/pubmed/37260449
http://dx.doi.org/10.3389/fendo.2023.1144422

Ejemplares similares